AbbVie submits EMA application for Skyrizi in adult Crohn’s
AbbVie submitted an EMA application for Skyrizi subcutaneous induction in adult Crohn's disease.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.